The obtained results revealed that 6-OHDA-treated neuronal-type SH-SY5Y cells exhibit the following characteristics in the created in vitro PD model: (i) metabolic damage (as proven by MTT assay), (ii) a high level of ROS, and (iii) reduced CREB activation. The gene discussed is CREB1; the disease is Parkinson disease.